Daily Stock List
Energy & Technology Corp. (ENGT)
SmallCapVoice reported previously on Energy & Technology Corp. (ENGT), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Lafayette, Louisiana, Energy & Technology Corp. is the holding company of Technical Industries, Inc., Energy Pipe, LLC, and Energy Technology MFG & Threading, LLC. The Company is a technology and essential commodities provider; they're a main source for rig, integrated systems, down hole tools, OCTG, linepipe, drillpipe, drilling tools and supply chain solutions. Energy & Technology lists on the OTC Markets' OTCQB. Originally founded on May 11, 1971 as an inspection company, Energy & Technology also has production facilities in Houston, Texas and Abbeville, Louisiana.
The Company provides an all-embracing drilling system for parts, down hole tools, engineering, non-destructive testing (NDT), storage, maintenance and other products and services. Currently, they serve customers throughout the oil patch of Louisiana and Texas and in Canada, Mexico, and in the Gulf of Mexico. Their customer base consists of major oil companies, steel mills, material suppliers, drilling companies, tool rental companies, and natural gas storage operators.
Their wholly owned subsidiary, Technical Industries, is a leader in non-destructive testing (NDT). Technical Industries is the developer of the patented VisonArray 3D pipe imaging technology that is critical for deep and offshore wells. Because of the nature of their technology, Energy & Technology maintains competitive advantages in offshore deep water and other onshore critical projects.
Technical Industries' patented ultrasonic systems have some of the largest OD and pipe length capabilities in the industry. They additionally have the deepest penetration capability offered for wall thickness measurement. The Company holds patents on certain exclusive inspection technology that allows oil and gas companies to use their current drill strings and other equipment to reach depths that were previously unreachable. This technology can make wells safer, increase the success rate for critical wells, and significantly reduce the chances of a failure.
In the oilfield pipe sales and storage segment, Energy & Technology uses a high-tech web based inventory management system. This system allows each client to view and track projects during processing, to locate inventory throughout the plant, and to access reports, bill of ladings, tally sheets, logs and other required information.
Energy Technology Manufacturing & Threading's new facility is completed and is fully operational. This facility is capable of threading, bucking, and the repairing of drill pipe, casing, and tubing up to 11 7/8" diameter. The plant has the capability to manufacture, thread, repair, and manufacture pup joints and marker joints to any length a customer requires, as well as to machine any threads for which specs can be furnished. This new facility brings Energy & Technology one-step closer to their goal of supplying all tubular services under one roof.
Today, Energy & Technology affiliate Technical Industries announced that their Chief Executive Officer, Mr. George M Sfeir, was selected to speak at the Offshore Middle East Conference January 21 – 23, 2013, at the Qatar National Convention Centre in Doha, Qatar. His paper, entitled "Inspection Methods, Equipment and Software Needed to Reach Deep Energy Reserves," was presented as part of SESSION 3: Asset Integrity.
Energy & Technology Corp. (ENGT), closed Wednesday's trading session at $0.54, even for the day. The average volume for the last 60 days is 900 and the stock's 52-week low/high is $0.056/$1.01.
LifeTech Industries, Inc. (LTCH)
PenniesPicks reported recently on LifeTech Industries, Inc. (LTCH), Investor Spec Sheet, Greenbackers, SmallCapNetwork, smartOTC, Stock Research Newsletter, Your Stock Alert, The Stock Brainiac, Stock Edge, Epic Stock Picks did earlier, and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Based in Palo Alto, California, LifeTech Industries, Inc. engages in the business of air to water generator distribution and technology licensing. Their business plan is to market and distribute AirWell air to water generation systems and license the technology and corresponding distribution rights to third parties around the world. LifeTech Industries' shares trade on the OTCBB.
LifeTech Industries entered into a Joint Venture (JV) Agreement, a Distribution Agreement, and a Technology License Agreement with LifeTech Japan Corp., a Japanese corporation. LifeTech acquired the worldwide exclusive right (excluding Japan) to make, use, sell or otherwise distribute LifeTech Japan's atmospheric water generator (AWG) products and technologies.
LifeTech Japan has also granted LifeTech Industries an exclusive and perpetual license to any and all of their patents, trademarks and all other intellectual property (IP) related to LifeTech Japan's AWG products, and the global exclusive right (excluding Japan) to assign, sublicense or otherwise transfer such rights in LifeTech Japan's technology to third parties, worldwide. All product design, production, and research and development is performed and managed by the Company's strategic partner, LifeTech Japan.
In November 2012, LifeTech announced that they launched the advanced atmospheric water generator: AirWell Water Systems. Their AirWell System is a highly advanced atmospheric water generator (AWG). It produces healthy drinking water through promoting and filtering the condensation of moisture from air. The AirWell method uses an advanced triple-step gathering system and a 12-step purification process to produce water that is free of chemicals, pollutants, contaminants and hormones.
The Company's manufacturer currently produces a home/office unit that generates approximately 15 to 30 liters of water daily. LifeTech's air to water generation and filtration technology is scalable; the Company is currently in the process of developing customizable units to service the water needs of an assortment of industries
In December 2012, LifeTech Industries signed an exclusive ten-country distribution agreement with SunPlex Ltd. LifeTech and SunPlex agreed to a five-year distribution plan. This plan involves targeting medical facilities, government agencies, schools and establishing water depots in Benin, Cameroon, Togo, Ghana, Cote d'Ivoire, Niger, South Africa, Tanzania, Chad, and Nigeria.
In addition, in December, LifeTech Industries announced the appointment of Dr. Abhimanyu Uberoi to the Company's international advisory board. Dr. Uberoi is currently serving as a cardiology fellow at Cedars-Sinai Hospital in Los Angeles, California.
LifeTech Industries, Inc. (LTCH), closed Wednesday's trading session at $0.275, down 8.33%, on 3,955 volume with 3 trades. The average volume for the last 60 days is 52,559 and the stock's 52-week low/high is $0.2501/$1.15.
Gran Colombia Gold Corp. (GCM.TO)
Today we are reporting on Gran Colombia Gold Corp. (GCM.TO), here at the QualityStocks Daily Newsletter.
Gran Colombia Gold Corp. is a gold and silver exploration, development and production company. Trading on the Toronto Stock Exchange, the Company's primary focus is in Colombia. They are building a strong production growth profile through exploration, development and bringing to production gold projects in the country. Gran Colombia's focus is on the development of the Segovia Operations and Marmato projects to generate strong cash flows in the short, medium and long term. Gran Colombia Gold has their headquarters in Toronto, Ontario. Their Colombia corporate office is in Bogota, D.C., Colombia, and their Colombia operations office is in Medellin.
Gran Colombia Gold is currently the largest underground gold and silver producer in Colombia. The Company has numerous underground mines in operation at their Segovia and Marmato Operations. Additionally, Gran Colombia is advancing a project to develop a large-scale, gold and silver mine at their Marmato operations.
The Segovia Operations include the El Silencio, Providencia and Sandra K gold mines. They also include the Las Aves and Poma Rosa Vein Systems (collectively referred to as Las Verticales), where a new mechanized mine will undergo development. In addition, the Segovia Operations include the Carla mine, which is approximately 5 kms southeast of the town of Segovia.
The Marmato project in Caldas department is in the heart of the Middle Cauca gold district approximately 80 km south of Medellin. Marmato is Gran Colombia Gold's flagship project. The Company acquired the project by way of their merger with Medoro Resources in June 2011. The project has first-rate infrastructure, being by the Pan American Highway with access to Medellin to the north and Manizales to the south. It has access to the national electricity grid that runs near the property.
At the end of January, Gran Colombia Gold announced that they entered into an asset purchase agreement with Industrias Infinito S.A. to purchase certain mine processing equipment for cash consideration of US$4.3 million. Industrias Infinito is a wholly owned indirect subsidiary of Infinito Gold Ltd. (IG.V).
Gran Colombia closed a US$100 million financing with the proceeds to be used for the Pampa Verde project at the Company's Segovia Operations in Colombia. This includes the construction of a 2,500 tpd mill; the development of a new mechanized underground mine to access new vein deposits as well as improve access to the existing mines. The equipment being purchased from Infinito includes certain of the primary components of a Carbon In Leach (CIL) process plant.
Gran Colombia Gold Corp. (GCM.TO), closed Wednesday's trading session at $0.25, even for the day, on 477,273 volume. The stock's 52-week low/high is $0.24/$0.60.
Beamz Interactive, Inc. (BZIC)
We are highlighting Beamz Interactive, Inc. (BZIC), here at the QualityStocks Daily Newsletter.
Beamz Interactive, Inc. is an interactive music product and technology company. The Company has created a new interactive laser controller technology that is usable to develop new market opportunities in a broad array of music, game, therapy and consumer applications.
Their technology portfolio includes multiple patents, patents pending and trade secrets covering interactive music, software, laser-based controllers, gaming applications and related designs and devices.
Arizona musician, Jerry Riopelle, founded the Company in 2001. His vision was to bring the fun and joy of music to everyone. The technology underwent development in 2008-2009, and a second-generation product was commercialized in late 2010. This new product was formally launched at the Consumer Electronics Show (CES) and the NAMM Music Industry Show in January 2011. Beamz Interactive has their corporate headquarters in Scottsdale, Arizona. The Company's shares trade on the OTC Bulletin Board.
Concerning the interactive laser controller technology, in its first application, Beamz developed a unique new music technology and product offering that brings music to literally everyone in a manner that has previously not been possible. Beamz allows people that have no musical background or training to play and enjoy music within minutes. However, it has the depth to enable accomplished DJs, artists and musicians to perform, compose and create very sophisticated interactive music. The technology is well protected by a suite of extensive patents and patents pending; Beamz Interactive files and owns a variety of software and music content copyright and trademarks.
In January, Beamz Interactive announced that their product roadmap would include proximity functionality in a new Beamz Pro MIDI laser controller to be released in the second half of 2013. With the use of MIDI communication, the future Beamz Pro product compatibility will expand beyond PC computing devices to MAC and tablet computing devices. The new Beamz Pro MIDI laser controller will additionally feature extra buttons for programming and native MIDI communication to control any music production, DJ or lighting applications.
Last week, Beamz Interactive announced that they engaged Satya Direct, a full service direct response and marketing management company, to support the launch of a new Beamz consumer interactive music product. The plan of this program is to include an integrated national TV, internet and social media marketing program. The scheduling of the launch is for the second half of 2013 when the company launches their new consumer product. Satya has started to develop the detailed campaign plan for Beamz.
Beamz Interactive, Inc. (BZIC), closed Wednesday's trading session at $2.00, even for the day. The average volume for the last 60 days is 208 and the stock's 52-week low/high is $0.75/$1.00.
GrowLife, Inc. (PHOT)
Greenbackers and MoneyTV reported this month on GrowLife, Inc. (PHOT), Bold Stocks, Stock Guru, HotShotStocks, Penny Stocks VIP, OTCPicks, SmallCapVoice, PennyTrader Publisher, WallstreetSurfers, SizzlingStockPicks, Stockgoodies did earlier, and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
GrowLife, Inc., formerly known as Phototron Holdings, Inc., has core holdings in creative technology-based products and services for the indoor gardening industry and specialty markets. GrowLife is a holding company for technology companies that make and market progressive grow technology products and life style products in the United States. The Company is a completely legal provider of highly effective indoor growing technologies that service the blossoming marijuana industry. GrowLife is based in Woodland Hills, California.
The Company's Brands include Stealth Grow LED, producer of hi-powered LED grow light products for indoor horticulture (www.stealthgrow.com), Greners.com, the online hydroponics superstore (www.greners.com) and Phototron, producer of hydroponic grow containers, designed to grow vegetables, herbs, flowers and fruits in any environment (www.phototron.com).
GrowLife's companies also include SGSensors.com. They are an operating division of SG Technology that manufactures and markets wireless monitoring and control equipment to operate all major grow room functions. GrowLife also has their GrowLife Productions. This business unit's dedication is to the promotion of GrowLife's core brands via co-production and co-sponsorship of entertainment, lifestyle, music, and film events across the U.S.
Moreover, the Company has their GrowLife Hydro, which owns and operates specialty hydroponics stores in Los Angeles (Southern California) and Cotai (Northern California). The Company also has their Cannabis.org. This is an information portal for the medical marijuana industry hosted and developed by GrowLife.
Recently, GrowLife announced that they entered into a strategic alliance with GrowOpp, LLC, a Nevada based company, for the initial production of the MEDIGROW climate controlled grow chambers for production of medical grade organic cannabis.
MEDIGROW is an important innovation and the expectation is that it will highlight GrowLife's lead in technology, especially technology for the production of medical grade organic cannabis. MEDIGROW systems incorporate much of GrowLife company technology including the SG Sensors product line. GrowLife and GrowOpp have agreed on cross licensing and incentives to produce the initial MEDIGROW production units. MEDIGROW's will be available for sale or lease only in States with legal medical marijuana programs.
GrowLife, Inc. (PHOT), closed Wednesday's trading session at $0.095, up 5.67%, on 36,525,525 volume with 1,924 trades. The average volume for the last 60 days is 5,800,760 and the stock's 52-week low/high is $0.01/$0.25.
Amerigo Energy, Inc. (AGOE)
OTCPicks, Premiumstockpicks, Pick Alerts, and Penny Stock Picks reported earlier on Amerigo Energy, Inc. (AGOE), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Trading on the OTC Markets' OTCQB, Amerigo Energy, Inc. operates in the oil and gas industry. The Company holds interest in leases and wells in the United States. Amerigo Energy derives their revenues from their producing oil and gas properties. The Company has their headquarters in Henderson, Nevada.
Amerigo Energy holds interest in the West Burke lease situated in Wichita County, Texas. They also hold interest in the Phillips B leases located in Cotton County, Oklahoma. In addition, the Company holds interest in the Melissa Hensley, Richard Hensley, DJ Hanks, as well as the Brooks Hensley wells situated in Kingfisher County, Oklahoma.
The substantial majority of the Company's interests are predominantly oil properties. These properties consist of working interests (WIs) in producing oil wells having proved reserves. Amerigo Energy's capital for investment in producing oil properties has been provided by the sale of common stock to the Company's shareholders.
Concerning the Company's most recent reported Results of Operations, for the three months ended September 30, 2012, Amerigo Energy generated revenues on producing oil and gas properties in the amount of $215. For the three months ended September 30, 2011, the Company generated $1,839 in revenues from producing oil and gas properties.
For the nine months ended September 30, 2012, the Company generated revenues on producing oil and gas properties in the amount of $879. For the nine months ended September 30, 2011, Amerigo Energy generated revenues on producing oil and gas properties in the amount of $35,063.
Amerigo Energy realized a net loss of $50,144 for the three months ended September 30, 2012. This is in comparison to a net loss of $48,318 for the three months ended September 30, 2011, an increase of $1,826. The increase in net loss was partially attributable to an increased use of consultants as compared to the three months ended September 30, 2011.
The Company realized a net loss of $145,657 for the nine months ended September 30, 2012. This is in comparison to a net loss of $249,097 for the nine months ended September 30, 2011, a decrease of $103,440.
Amerigo Energy, Inc. (AGOE), closed Wednesday's trading session at $0.14, up 1,300.00%, on 318,585 volume with 73 trades. The average volume for the last 60 days is 4,128 and the stock's 52-week low/high is $0.005/$0.04.
Data Storage Corp. (DTST)
Stock Twiter, Penny Dreamers, RockingPennyStocks, AlphaPennyStock, Investor News Source, and Stock Guru reported earlier on Data Storage Corp. (DTST), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Data Storage Corp. provides professional technology services. These services encompass disaster recovery and business continuity of data with a focus on regulatory compliance of electronic information under the current environment. Incorporated in Delaware on August 29, 2001, the Company garners their revenues from the sale and subscription of solutions that provide businesses protection of critical electronic information.
Data Storage has their corporate headquarters in Garden City, New York. They maintain and operate Data Centers in Rhode Island and New York; and, they maintain DSC equipment under a strategic alliance or vendor relations in both, and Massachusetts. This totals three data centers providing clients with data replication and redundant data protection in specific applications.
Data Storage delivers and supports an extensive range of premium technology solutions, which store, protect, optimize and leverage information; minimize downtime and recovery of information. Clients depend on the Company to manage data growth, ensure disaster recovery and business continuity, strengthen security, reduce capital and operational expenses, and to meet increasing industry state and federal regulations.
Primarily, Data Storage's services consist of professional services implementing high availability replication (mirroring of data) of client data between the client's data center or one of the Company's three data centers. Their services also consist of email storage and archival; off-site data back-up and recovery; continuous data protection; data de-duplication; telecom recovery services; and, virtual tape libraries.
The Company provides solutions and services to business, government, education as well as healthcare industries through taking advantage of leading technologies such as Virtualization, Cloud Computing and Green Information Technology (IT).
On June 17, 2010, the Company's wholly owned subsidiary Data Storage Corporation, a Delaware corporation (Data Storage DE) and SafeData, LLC, a Delaware Limited Liability Company (LLC) entered into an Asset Purchase Agreement setting forth the acquisition of SafeData's assets.
Data Storage Corp. (DTST), closed Wednesday's trading session at $0.087, up 74.00%, on 29,900 volume with 4 trades. The average volume for the last 60 days is 24,509 and the stock's 52-week low/high is $0.0361/$0.15.
VoodooVox, Inc. (VVX.TO)
Today we are highlighting VoodooVox, Inc. (VVX.TO), here at the QualityStocks Daily Newsletter.
VoodooVox, Inc. uses consumer analytics to provide smarter mobile advertising services via the cloud to publishers, advertisers and operators. VoodooVox represents the combined assets and knowledge base of three companies: Call Genie, Inc., UpSnap Services, LLC, and VoodooVox. The Company lists on the Toronto Stock Exchange. VoodooVox has their headquarters in Toronto, Ontario. They also have offices in Calgary, Alberta, Williamstown, Massachusetts, and Aarhus, Denmark.
The Company now processes billions of advertising transactions for a marquee list of international clients and partners. Currently, VoodooVox deploys their solutions in 11 countries worldwide. VoodooVox has a large database of demographic analytics. Their detailed audience profiles let publishers and carriers fine-tune messages, content, features and pricing. Advertisers can pinpoint targeting for their message via VoodooVox's premium-value ad network.
VoodooVox's primary markets are mobile web and app publishers, advertisers and agencies, as well as mobile carriers. Some of the Company's customers include AT&T, Batelco, DexOne, du (Dubai), Eniro, Etisalat, kgb, Le Numero, Microsoft, NBC, Newsphone, Omantel, Orange, SuperMedia, TCS, TDC, Telecom Egypt, Telegate (France), TelePost, TELUS, The Number, Verizon, and Yell.
For publishers, VoodooVox supplies targeted ads from their premium-value mobile ad network and from other sources. For advertisers, they provide the ability to create and manage ad campaigns in their premium-value mobile ad network. For operators – mobile carriers and other service providers – the Company offers a wide spectrum of operator services and consumer search products.
VoodooVox provides a family of technologies for telecommunications companies and directory assistance service providers on a licensed product basis. These may be hosted by VoodooVox or installed in a customer's data center. These include the VoodooVox Ad Exchange - advanced software for managing multi-media ads.
These also include their Call center product suite. This suite features the robust and flexible Directory Workstation, Directory Search Engine, Directory Data Manager, Open Integration Framework and Voice Response products, supporting a range of business models. VoodooVox also has their Referred Call service. It turns calls to disconnected numbers into a revenue opportunity while improving the caller experience.
VoodooVox, Inc. (VVX.TO), closed Wednesday's trading session at $0.005, even for the day, on 109,000 volume.
Rainbow Coral Corp. (RBCC)
The QualityStocks Daily Newsletter would like to spotlight Rainbow Coral Corp. (RBCC). Today, Rainbow Coral Corp. closed trading at $0.39, off by 2.50%, on 228,190 volume with 67 trades. The stock’s average daily volume over the past 60 days is 93,992, and its 52-week low/high is $0.27/$2.67.
Rainbow Coral Corp. reported today that they are kicking off a new investor outreach campaign and have hired an IR group dedicated to enhancing market visibility and RBCC's overall reach when it comes to executing on their strategic growth initiatives. CEO of RBCC, Patrick Brown, mapped out what is forecasted to be an incredible year for the company and welcomed the dynamic new IR partners, confident in the knowledge that this firm possesses the in-depth industry knowledge and relevance required for RBCC to closely engage current and potential investors. The company's biotech division, Rainbow BioSciences, is leaning heavily into the 3D Bio-Assembler technology owned by partner Nano3D BioSciences, and the potential to grow functional organs from scratch is really turning heads.
Rainbow Coral Corp. (RBCC), via wholly owned subsidiary Rainbow Biosciences, continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. The company specifically pursues opportunities that offer short-term marketability and commercialization potential in key areas like Alzheimer's, Parkinson's, and Cancer.
Bioscience technology is a growing, dynamic field of innovation that applies life processes to practical uses, such as the manufacturing of medical devices and the development of new bioscience procedures. From pharmaceuticals to pacemakers, genetically engineered plants to gene therapy, bioscience technology can be found virtually anywhere.
The pending joint venture with Amarantus BioScience to develop and market new therapies and treatments for neurological diseases and physical traumas is a great example of the initiatives underway. In recent news, Amarantus licensed a highly promising diagnostic blood test that could become an invaluable new tool in Alzheimer's clinical trials where patient recruitment errors occur often due to inaccurate diagnosis.
The global biotech industry, currently valued at more than $84.6B, allows new players with bright ideas to quickly grab market share and create completely new markets. The exciting initiatives being driven forward by Rainbow Coral promise to transition today's leading-edge research into practical, affordable treatments for people who need them most. Disclaimer
Rainbow Coral Corp. Company Blog
Rainbow Coral Corp. News:
RBCC Retains New IR Group to Optimize Investor Outreach, Relay Key Growth Plans
RBCC: n3D Technology Could Lead to Lab-Grown Implantable Organs
RBCC Partner N3D Could Revolutionize Toxicity Testing
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.092, on 8,748,319 volume with 458 trades. The stock’s average daily volume over the past 60 days is 4,311,471, and its 52-week low/high is $0.0275/$0.155.
Advaxis, Inc. Chairman and CEO, Tom Moore, was featured in a new audio interview with nationally established corporate investor relations firm SmallCapVoice.com, Inc., where he covered the company's business model, immunotherapy pipeline, targeted markets, and recent developments. This brings a great deal of exposure to ADXS thanks to SmallCapVoice's known ability to help emerging growth companies build a following among retail and institutional investors. The interview also covered background info on management, as well as several of the company's near-term goals, and can be heard online at http://dtg.fm/A4nA.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Chairman and CEO of Advaxis Featured in Exclusive SmallCapVoice Interview
Advaxis to Present at the 15th Annual BIO CEO & Investor Conference
Advaxis to Present at the 6th Annual OneMedForum
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.025, up 38.89%, on 73,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 154,660, and its 52-week low/high is $0.001/$0.025.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Inc. Reaches Funding Agreement With Private Equity Group
Consorteum Holdings Files Form 10-K Report With the Securities and Exchange Commission
CORRECTION -- Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.80, up 15.94%, on 4,950 volume with 6 trades. The stock’s average daily volume over the past 60 days is 2,184, and its 52-week low/high is $0.06/$3.10.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.
Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data. To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen's Collaborators Identify Definitive Precursor for Adult Blood and the Immune System
Vistagen Therapeutics Successfully Completes Final Phase 1 Safety Study of AV-101
VistaGen Therapeutics to Present at Noble Financial Capital Markets Ninth Annual Equity Conference
Today before the opening bell, Rainbow Coral announced it is launching a new investor outreach campaign. The company has retained an up-and-coming, dynamic investor relations group committed to enhancing the visibility and reach of RBCC’s strategic growth initiatives.
“Our new investor relations partners have the hands-on expertise and industry relevance we need to thoroughly communicate our corporate plans and activities to current and potential investors as timely and efficiently as possible,” stated RBCC CEO Patrick Brown. “We’re confident that 2013 is shaping up to be an incredible year for RBCC, and we want to make sure that it doesn’t go unnoticed.”
Rainbow BioSciences, RBCC’s biotech division, has acquired a high interest in the Bio-Assembler, a biotech device owned by RBCC partner Nano3D BioSciences. This new technology enables scientists to grow cells in a three-dimensional environment using nanoparticles that produce magnetic fields to lift cells from the bottom of petri dishes.
The Bio-Assembler enables 3D cultures to form tissues that more closely resemble those found in the human body, versus conventional cell cultures grown on flat surfaces. The technology may help drastically reduce the cost of developing new drugs and eliminate the use of animal testing. Additionally, the Bio-Assembler has the potential to grow functional organs.
Rainbow Coral is closely working with its partner to further develop and market this profound technology worldwide. Retaining an investor relations group is part of the company’s plan to prepare for the execution of a far-reaching growth strategy.
For more information on Rainbow BioSciences, visit www.rainbowbiosciences.com/investors.html
SmallCapVoice.com announced today that its interview with Advaxis is now available. The interview can be heard at http://dtg.fm/A4nA.
Tom Moore, Chairman and CEO of Advaxis, discussed the company’s business model, immunotherapy pipeline, targeted markets, and recent developments. The interview also includes background information on the management team and the company’s near-term goals.
“Thanks to having several trials that are either underway or nearing completion, an investor can review the preliminary clinical benefits and safety profile of our novel platform technology. I would like to encourage the investment community to visit our website and learn more about our next-generation immunotherapies,” stated Mr. Moore.
Advaxis has more than fifteen distinct constructs in various stages of development, many in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
For more information, visit www.advaxis.com
Eastern Resources reported executing an advisory agreement today with a NY-registered broker/dealer that focuses heavily on the company’s sector, precious metals and mining, whereby the investment bank will assist ESRI in raising some $200M for taking their Montana Tunnels Mine and Golden Dream Mine projects to the next level. This considerable sum would enable significant capital restructuring on ESRI’s part and allows them the liquidity needed to maximize working capital efforts at both of these promising resource sites.
CEO of ESRI, Patrick Imeson, noted that the selection of this particular investment bank for the advisory role was attributable not only to the vast experience within the industry retained by their key people, but the familiarization already obtained by the firm with regard to ESRI’s assets. This level of intricate, nuanced knowledge will prove indispensible moving forward with financing efforts, and Imeson expressed supreme confidence in the adroitness of the firm when it comes to getting the most out of financing/development of the company’s rich Montana resource portfolio.
The Elkhorn Claims, controlled by ESRI’s wholly-owned subsidiary, is just 13 miles outside Boulder, Montana. Acquired from major player Newmont in 1998, some 1.6M ounces of gold has been delineated on the property (via 400k feet of core drilling) and we are looking at four choice gold and gold-copper deposits here. The most advanced of the three deposits, the Golden Dream Mine, which is fully permitted and has begun underground development (1k feet already done), incorporates a 1.17M-ton recoverable deposit (probable mineral reserve) containing some 258k oz Au, with another 9.5M pounds of copper.
Only roughly 1.2k feet of further digging of the main access ramp and they should be right in the deposit at Golden Dream. Estimates of 50k ounce/year on 5-year mine life (deposit is open at depth and on strike) operation that would output via truck to the Montana Tunnels Mine, at the 1k ton/day mill in the concentrating facility, look very promising indeed. The rest of the access ramp work should only take six months or so and markets will be expecting an update as the end of the work approaches.
Speaking of the Montana Tunnels Mine and mill, which is run via the company’s wholly-owned, Montana Tunnels Mining Inc. subsidiary, we have a producer that kicked off back in 1986 under a prior operator and has produced upwards of 1.7M oz Au, 30.8M oz Ag, 400M pounds of lead, and another 1.1B pounds of zinc. The company actually has three permitted mines in the complex, which is located just outside Helena, Montana, and with the (proven and probable) 38M ton “M” Pit expansion at the primary mine currently in-hand, we have a second major development front for working capital to attend to.
The Montana Tunnels Mine was actually put on care and maintenance back in 2009 pending permitting of this exciting expansion project, whose sizeable ore target contains some 480k oz Au, 7.9M oz Ag, 124M pounds of Pb, and another 370M pounds of Zn. Looks like about 16 months of pre-production work over here, but investors will be really eager to see how the “M” Pit expansion shapes up, seeing as how we are a looking at a tight production pipeline with a mine life of around 8.5 years (despot is open at depth).
For more information on Eastern Resources, please visit www.EasternResourcesInc.com
PureSafe Water Systems has entered into strategic agreements with Global Equipment Marketing Inc. (GEM) and Engineering Technologies Group Inc. (ETG) to enhance PureSafe’s ability to meet immediate and long-term market demand for the company’s mobile water purification systems. The agreement sent shares of PureSafe soaring 153% today on heavy volume.
“This is a significant milestone for PureSafe,” Adam Seltzer, managing director of Dominick and Dominick, investment advisor to PureSafe, stated in the press release. “It has enabled the company to engage two renowned firms that have significant experience and expertise on both the engineering side of the business, as well as the sales, marketing and distribution of equipment. This partnership is a major step forward and should allow PureSafe to expedite manufacturing in order to meet market demand. This relationship also gives PureSafe the ability to eventually roll-out its product worldwide without taking on the expenses of having direct sales, marketing, distribution and engineering costs ‘in house.’ We expect that this model will allow the company to maximize value using the expertise of GEM and ETG to enhance its water treatment technology and expedite distribution capabilities.”
GEM distributes large-scale production and process equipment throughout the world. By operating as PureSafe Water System Sales (PWSS), the company will tap into its existing dealer network to establish a global distribution network, adding new dealers and representatives as well as secure direct sales and alliances needed to distribute the PureSafe product.
ETG is a full-service engineering firm specializing in general equipment and process engineering, environmental services, and the design and supply of various engineered products. Per its arrangement with PureSafe, ETG will provide engineering services resulting in a more easily and efficiently manufactured PureSafe product. Additional product line expansion, enhancements, and developments will also originate here.
Leveraging the strengths of both partners, PureSafe plans to accelerate global sales, implement a value engineering program, and improve product manufacturing.
“The engineering review and value engineering program we are embarking on will create a product that will be more easily manufactured with the highest level of quality and reliability built-in,” Denis Roy, vice president of ETG stated. “This program will also be the foundation for an ever-expanding line of water filtration products to meet the needs of world markets.”
For more information visit www.puresafewatersystems.com
Today's Top 3
The QualityStocks Public Company Sponsor News